The nation's three leading drug wholesalers have received subpoenas from the New York attorney general, Eliot Spitzer, that appear to signal a broad inquiry into the behind-the-scenes market in which pharmaceuticals are purchased and resold, sometimes several times, before they reach consumers.
Many of the drugs traded in this secondary bazaar are legitimate and are the excess inventory from overstocked warehouses. But critics of the system say the discounted prices wholesalers obtain through the secondary system are rarely passed to consumers.
